09.04.2019 09:00:00

DSM - Repurchase of shares (1 – 5 April 2019)

HEERLEN, Netherlands, April 9, 2019 /PRNewswire/ --

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 144,066 of its own shares in the period from 1 April 2019 up to and including 5 April 2019 at an average price of €99.84. This is in accordance with the repurchase announced on 14 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was €14.4 million. 

     (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )

For more detailed information see 'Daily transaction details Share Repurchase Program starting 1 April 2019'.

DSM - Bright Science. Brighter Living.™ 
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. 

More information can be found at www.dsm.com.

Or find us on:

Facebook 
 Twitter 
LinkedIn
YouTube

    PRN NLD

Nachrichten zu DSM NVmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu DSM NVmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DSM NV 108,95 -0,86% DSM NV